These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 25403902

  • 1. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
    Nagata Y, Inaba M, Imanishi Y, Okazaki H, Yamada S, Mori K, Shoji S, Koyama H, Okuno S.
    Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
    [Abstract] [Full Text] [Related]

  • 2. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
    Okuno S, Ishimura E, Tsuboniwa N, Norimine K, Yamakawa K, Yamakawa T, Shoji S, Mori K, Nishizawa Y, Inaba M.
    Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
    [Abstract] [Full Text] [Related]

  • 3. Nutritional Therapy with Vitamin K1 Is Effective in the Improvement of Vitamin K Status and Bone Turnover Markers in Patients with Severe Motor and Intellectual Disabilities.
    Kuwabara A, Nagae A, Kitagawa M, Tozawa K, Kumode M, Tanaka K.
    J Nutr Sci Vitaminol (Tokyo); 2020 Feb; 66(3):278-284. PubMed ID: 32612091
    [Abstract] [Full Text] [Related]

  • 4. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 5. Carboxylated and intact osteocalcin predict adiponectin concentration in hemodialyzed patients.
    Kuźniewski M, Fedak D, Dumnicka P, Kapusta M, Stępień E, Chowaniec E, Krzanowska K, Krzanowski M, Chmiel G, Solnica B, Sułowicz W.
    Ren Fail; 2016 Aug; 38(3):451-7. PubMed ID: 26822199
    [Abstract] [Full Text] [Related]

  • 6. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K, Perrea D, Doumouchtsis S, Tziamalis M, Poulakou M, Vlachos I, Kostakis A.
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [Abstract] [Full Text] [Related]

  • 7. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I, Shidara K, Okuno S, Yamada S, Imanishi Y, Mori K, Ishimura E, Shoji S, Yamakawa T, Inaba M.
    Life Sci; 2012 Jan 30; 90(5-6):212-8. PubMed ID: 22154904
    [Abstract] [Full Text] [Related]

  • 8. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
    Goto K, Goto S, Fujii H, Watanabe K, Kono K, Nishi S.
    J Bone Miner Metab; 2019 Nov 30; 37(6):1075-1082. PubMed ID: 31214836
    [Abstract] [Full Text] [Related]

  • 9. Bone responsiveness to parathyroid hormone is negatively associated with parathyroid hormone-lowering drug use in patients undergoing hemodialysis: a cross-sectional study.
    Tominaga N, Yonaha T, Yamanouchi M, Sumi H, Taki Y, Shibagaki Y, Shiizaki K, Yano S.
    BMC Nephrol; 2021 Aug 09; 22(1):275. PubMed ID: 34372813
    [Abstract] [Full Text] [Related]

  • 10. Mineral-bone metabolism markers in young hemodialysis patients.
    Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E.
    Clin Biochem; 2011 Dec 09; 44(17-18):1425-8. PubMed ID: 21933667
    [Abstract] [Full Text] [Related]

  • 11. Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.
    Liu Y, He Q.
    Clin Lab; 2015 Dec 09; 61(7):839-43. PubMed ID: 26299086
    [Abstract] [Full Text] [Related]

  • 12. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
    Nagasue K, Inaba M, Okuno S, Kitatani K, Imanishi Y, Ishimura E, Miki T, Kim M, Nishizawa Y.
    Biomed Pharmacother; 2003 Mar 09; 57(2):98-104. PubMed ID: 12842495
    [Abstract] [Full Text] [Related]

  • 13. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.
    Nimptsch K, Rohrmann S, Nieters A, Linseisen J.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 09; 18(1):49-56. PubMed ID: 19124480
    [Abstract] [Full Text] [Related]

  • 14. sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.
    Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Tsigris C, Kostaki MA, Perrea DN.
    J Endocrinol Invest; 2007 Oct 09; 30(9):762-6. PubMed ID: 17993768
    [Abstract] [Full Text] [Related]

  • 15. The association between dietary vitamin K intake and serum undercarboxylated osteocalcin is modulated by vitamin K epoxide reductase genotype.
    Nimptsch K, Nieters A, Hailer S, Wolfram G, Linseisen J.
    Br J Nutr; 2009 Jun 09; 101(12):1812-20. PubMed ID: 19025725
    [Abstract] [Full Text] [Related]

  • 16. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z, Konieczna M, Wańkowicz Z.
    Pol Merkur Lekarski; 2004 Aug 09; 17(98):138-41. PubMed ID: 15603322
    [Abstract] [Full Text] [Related]

  • 17. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.
    Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N.
    Osteoporos Int; 2012 Feb 09; 23(2):761-70. PubMed ID: 21437719
    [Abstract] [Full Text] [Related]

  • 18. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep 09; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 19. Effects of calcitriol on type 5b tartrate-resistant acid phosphatase and interleukin-6 in secondary hyperparathyroidism.
    Lu KC, Tseng CF, Wu CC, Yeung LK, Chen JS, Chao TY, Janckila AJ, Yam LT, Chu P.
    Blood Purif; 2006 Sep 09; 24(5-6):423-30. PubMed ID: 16888370
    [Abstract] [Full Text] [Related]

  • 20. Vitamins K and D deficiency in severe motor and intellectually disabled patients.
    Sakai T, Shirai T, Oishi T.
    Brain Dev; 2021 Feb 09; 43(2):200-207. PubMed ID: 33139126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.